[1]
M. D. Kumar, S. Chakraborty, and B. Mukherjee, “FEEBLE REGULATORY AFFAIRS WEAKEN THE BACKBONE OF INDIAN DRUG INDUSTRIES”, Int J Drug Reg Affairs, vol. 2, no. 4, pp. 1-13, Dec. 2018.